ISSN: 2530-0164

Indexed in:

Index Medicus/MEDLINE, Excerpta Medica/EMBASE, SCOPUS, Science Citation Index Expanded, Journal Citation Reports/Science Edition, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

1.8

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.474

View more metrics

Journal Information

Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

TMEM-127 gene mutation: A rare genetic entity associated with metastatic bilateral pheochromocytoma

Mariana Ornelas, Eduarda Resende, Pedro Gouveia, Maritza Sá, Margarida Ferreira

10.1016/j.endinu.2024.09.004

Available online 9 December 2024

PTH levels and establishment of reference intervals: Impact of vitamin D and renal function

Luis Agustín Ramírez Stieben, María Lorena Brance, Marina Verónica Belardinelli, Diamela Bolzán, Estefanía Pustilnik, Rodolfo Néstor Feldman, Lucas Ricardo Brun

10.1016/j.endinu.2024.09.003

Available online 6 December 2024

Estado de la prevención de la diabetes mellitus tipo 1: promesas y realidades

Ana M. Wägner, Marta Hernández García

10.1016/j.endinu.2024.10.002

Available online 2 December 2024

Tumor fibroso solitario en la glándula tiroides como hallazgo incidental

Luis Francisco de Miguel Rodríguez, Julieta Romina Arbat, Katherine García Malpartida, Pablo Fernández Collazo, Carlos Morillas Ariño

10.1016/j.endinu.2024.09.002

Available online 19 November 2024

Terapia farmacológica hipolipemiante para la reducción del riesgo cardiovascular en la diabetes. Visión clínica del Grupo de Trabajo de Enfermedad Cardiovascular de la Sociedad Española de Diabetes

Juan Pedro-Botet, Francisco Arrieta, Manuel Botana, José A. Gimeno-Orna, José I. Martínez-Montoro, Emilio Ortega-Martínez de Victoria, Josep Ribalta, Víctor Sánchez-Margalet, ... en nombre del Grupo de Trabajo de Enfermedad Cardiovascular de la Sociedad Española de Diabetes

10.1016/j.endinu.2024.09.001

Available online 8 November 2024